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Here we present a system for adenovirus detection and genotyping based on PCR amplification and2
phylogenetic analysis of a conserved hexon gene fragment. The system was validated using 1573
sequences (86 previously typed and 71 clinical samples) and correctly identified species and serotype in4
100% and 84% of sequences respectively. Clinical correlation yielded known and novel associations5
between specific serotypes and clinical presentation.6
7
3
Human adenoviruses (HAdVs) cause a wide range of clinical syndromes and are being increasingly1
recognized in cases of severe or fatal pneumonia, hemorrhagic cystitis, hepatitis, or disseminated disease2
in pediatric bone marrow transplant recipients (15). HAdVs are classified into six species, A to F,3
comprising 51 serotypes (7). Serotype identification is critical for epidemiological surveillance,4
detection of new strains, assessment of treatment efficacy and understanding HAdV pathogenesis (19).5
Molecular typing methods have been established to circumvent practical problems associated6
with traditional serum neutralization studies (1-4, 12, 13, 16, 17, 25, 26). Molecular methods also have7
disadvantages; restriction fragment length polymorphism analysis of adenoviral DNA may fail if8
mutations are present within the restriction site and multiplex PCR assays are currently not able to9
discriminate between serotypes (21, 30). PCR amplification of the hypervariable portion of the hexon10
gene followed by DNA sequencing has recently been proposed as a typing method; however, this11
method was unable to discriminate between species B and E and was validated with only 10 clinical12
samples (25).13
We have previously detected HAdV infection in clinical samples using generic HAdV primers in14
singleplex (6) and multiplex assays; these assays have been extensively validated and used routinely for15
clinical diagnosis (8, 10). Here we report that DNA sequencing and phylogenetic analysis of this16
moderately conserved region (aa 540 to 662) of the hexon gene (11) is sufficient to allow HAdV17
speciation and, in most cases, serotype identification. We have confirmed and also noted new18
associations between specific serotypes and clinical presentations.19
HAdV infection was detected by generic PCR in 46 clinical specimens and 25 HAdV culture20
isolates sent for diagnostic evaluation at Centro Nacional de Microbiologia, ISCII, Spain; clinical21
materials, patient characteristics and alternate methods to detect HAdV infection, such as cell culture,22
direct immunofluoresence assay and latex agglutination, are listed in Table 1.23
For comparison, 47 prototype HAdV strains, each representing a distinct serotype, were24
obtained from the American Type Culture Collection (Manhassas, VA) or from an existing collection in25
our institute (Table S1).26
Nucleic acids were extracted (9) and the singleplex PCR assay performed as previously27
described (6). Briefly, 5 l of the nucleic acid extraction were added to 45 l of reaction mixture28
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 500M each dNTP, 4 mM MgCl2, 2.5 units of Taq29
polymerase (Amplitaq; Perkin-Elmer Cetus, Norwalk) and 20 pmol of degenerate primers ADHEX1F30
(5’CAACACCTAYGASTACATGAA3’) and ADHEX1R (5’KATGGGGTARAGCATGTT3’).31
Temperature and time profiles were: 94ºC for 1 min, 50ºC for 1 min and 68ºC for 1 min for 30 cycles,32
and a final incubation at 68ºC for 5 min. Amplification products (475 bp) from this PCR reaction were33
visualized by agarose gel electrophoresis and sequenced directly. For clinical samples where direct34
sequencing was not possible due to low DNA yield, two independent nested reactions were performed35
4
with 20 pmol of degenerate primer ADHEX2F (5’CCCITTYAACCACCACCG3’) and ADHEX1R or1
20 pmol of ADHEX1F and ADHEX2R (5’ACATCCTTBCKGAAGTTCCA3’). Amplified products2
were purified and sequenced in both directions using an automated ABI PRIMS 377 model sequencer.3
The sequences were deposited in the GenBank sequence database under accession numbers AY8198094
to AY819926.5
The consensus sequence was compared and aligned against other sequences from samples or the6
DNA database using the program CLUSTAL X (version 1.83). The relationships between individual7
viruses were established using Neighbour-joining, UPGMA, and nucleotide substitution methods8
(Tamura-Nei, Kimura-2p, Jukes-Cantor). Phylogenetic trees were reconstructed through the Neighbour-9
joining method (MEGA package, version 3) by 1000 times bootstrap re-sampling. Pairwise comparisons10
were also made by global alignment using the Needleman Wunsch algorithm (20), implemented by a11
program from EMBOSS (22).12
The phylogenetic tree showed 6 different clusters representing species A to F at the nucleotide13
(Figure 1) and amino acid levels with bootstrap values ranging from 59 to 99. Results obtained when14
the 46 clinical samples and the 25 HAdV isolates were compared with sequence of the reference strains15
are presented in Table 2. All clinical samples were speciated, and 42 (91%) of 46 were serotyped. All16
25 isolates were speciated, and 22 (88%) of 25 were serotyped. Phylogenetic analysis revealed17
subclusterings, except in species E, D and B2; serotype HAdV-7 could be separated in to two lineages18
(17). Serotypes of species D were not clearly discriminated because of high homology. Serotypes 11, 3419
and 35 of subgroup B2 were indistinguishable. HAdV-4 is the only member of species E. The20
Needleman Wunsch pairwise algorithm produced identical results to those obtained via phylogenetic21
analyses (Table 2 and S2). Although both analyses permitted accurate HAdV classification, pairwise22
similarity analysis has the advantage of speed and simplicity.23
Using our method, we found new associations between specific clinical syndromes and HAdV24
serotypes (Table 3). Typically, respiratory tract diseases are associated with species B1, C and E,25
gastrointestinal diseases with species A and F, eye diseases with species D and E, and kidney and26
urinary tract diseases with species B2.27
Acute respiratory diseases due to HAdV are attributed primarily to serotypes 3, 4, 7, 14 and 2128
(species B and E) (17, 40 36, 37). We observed serotypes 1, 2, 5, and 6 (species C) and species D.29
Pneumonia in children has been associated with serotypes 1-3 and 7, whereas pneumonia in adults is30
predominantly associated with serotypes 4 and 7. We also found serotypes 5 and 6 in young children,31
and subgroup B2 in immunosuppressed patients.32
Gastrointestinal manifestations of HAdV infection include diarrhea and hepatitis. In addition to33
serotypes 40 and 41 (4, 23, 28), we identified cases of diarrhea associated with serotypes 6, 12, 16, 31,34
and a member of species D. The significance of these findings is not clear as members of species C may35
5
be excreted in faeces during subclinical infection. HAdV hepatitis has been reported in children1
recipients of liver transplants associated with serotypes 1, 2 and 5 (species C); in this study we detected2
the remaining member of species C, serotype 6, in a case of fatal hepatitis.3
Epidemic keratoconjunctivitis has been associated with serotypes 8, 19 and 37 (species D) and4
serotype 11 (species B2). Our sequences revealed not only serotype 8 (species D), but also serotypes 45
and 7 (species E and B1, respectively). Adenovirus 4 (species E) can cause either respiratory or mild6
ocular infections (29) and nosocomial epidemic conjunctivitis in Japan (5, 27).7
Cases of acute hemorrhagic cystitis in young children have been associated with species B28
serotypes 11 and 21 and fatal infections due to species B1, serotypes 3 and 7, have been reported (14,9
18, 23, 31). In our study, this disease is associated with B1 serotypes 16 and 14 (species B1 and B2),10
and an indistinguishable member of the cluster 11, 34, 35 (species B2). The fact that subgroups B1 and11
B2 use different cellular receptors for viral entry underscores the importance of typing HAdV for12
epidemiology and pathobiology (24).13
Finally, we found serotypes 4 and 5 (species E and C) in throat swabs of 4 patients with fever,14
morbilliform rash, Koplik’s spots, and cough who had a history of MMR vaccination and were negative15
for measles and rubella. To our knowledge this is the first report of HAdV presenting as a syndrome16
compatible with measles infection.17
Using the database and classification system from this study, we have deployed a website18
(www.greeneidlab.columbia.edu) wherein clinical laboratories can submit hexon sequences to generate19
an automatic report detailing the serotype, date and location of the most similar sequence isolate in the20
database. This system will allow new genotypes to be readily identified because the classification21
scheme will fail to relate them to any described serotype. Epidemiological surveillance of HAdV22
serotypes will improve our understanding of the global burden of HAdV infection. High-throughput23
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Figure 1. Nucleotide sequences were aligned with Clustal W. Phylogenetic analyses were performed2
using the Kimura two-parameter model as a model of nucleotide substitution and using the neighbour3
joining method to reconstruct phylogenetic trees (MEGA version 2.1 software package). The statistical4
significance of the phylogenies constructed was estimated by bootstrap analysis with 1,0005
pseudoreplicate data sets.6
7
Table 1. Summary of patient data including clinical syndrome, sample type, subject age, epidemiology,8
cell cultures and direct antigen detection results.9
10
Table 2. Typing of HAdV: comparison of phylogenetic and pairwise alignment methods.11
12
Table 3. Summary of the HAdV serotype infections associated with disease or persistence.13
14
PROPOSED SUPPLEMENTARY MATERIAL15
Table S1. Adenovirus nucleotide sequences of reference or wild type strains from GenBank database.16















SO3360_01 Bronchiolitis NPA 1,6 yr sporadic cont - ND
SO3790_03 Bronchiolitis NPA <5yr sporadic + + ND
SO4010_04 Bronchiolitis NPA 1,1 yr sporadic - - ND
SO4363_04 Bronchiolitis NPA 10 mo sporadic ND - ND
SO4366_04 Bronchiolitis NPA 11 mo sporadic ND - ND
SO4390_04 Bronchiolitis NPA <5yr sporadic cont + ND
SO4405_04 Bronchiolitis NPA <5yr sporadic + + ND
SO4408_04 Bronchiolitis NPA <5yr sporadic ND - ND
SO4425_04 Bronchiolitis NPA 1,5 yr sporadic + + ND
SO4427_04 Bronchiolitis NPA <5yr sporadic + + ND
SO4429_04 Bronchiolitis NPA <5yr sporadic - - ND
G1066_01 Influenza-like TS 33 yr sporadic - - ND
G1108_01 Influenza-like TS 26 yr sporadic - - ND
G1253_02 Influenza-like TS 2 yr sporadic - - ND
G1507_04 Influenza-like TS 33 yr sporadic - ND ND
G1508_04 Influenza-like TS 25 yr sporadic - - ND
G1634_04 Influenza-like TS 29 yr sporadic - - ND
R1625_04 Pneumonia NW 20 d sporadic ND ND ND
1184X_93 Pneumonia BAL <5yr sporadic + ND ND
R1629_04 HIV+, Pneumonia BAL 30 yr sporadic - ND ND
591Fi_01 LRI BAL sporadic - ND ND
992Fi_01 LRI BAL sporadic - ND ND
593Fi_01 LRI BAL sporadic - ND ND
130C_99 LRI NW 19 mo sporadic ND ND ND
R1612_04 BMTx, Hemorrhagic cystitis NW 14 yr sporadic - ND ND
226I_03 BMTx, Hemorrhagic cystitis Urine 40 yr sporadic ND ND ND
1938I_89 BMTx, Hemorrhagic cystitis Urine 30 yr sporadic + ND ND
1370I_03 BMTx, Hemorrhagic cystitis Urine 15 yr sporadic ND ND ND
411I_04 LITx, Fatal Hepatitis Liver N 5 yr sporadic ND ND ND
1803F_03 Exanthema, fever TS 3 yr sporadic ND ND ND
2549F_03 Exanthema, fever TS 4 yr sporadic ND ND ND
1804F_03 Exanthema, fever TS 6 yr sporadic ND ND ND
1292F_01 Exanthema not fever TS 2 yr sporadic + ND ND
824O_02 Keratoconjunctivitis Eye swab 56 yr sporadic ND ND ND
928O_04 Keratoconjunctivitis Eye swab 30 yr Out-Jaén ND ND ND
926O_04 Keratoconjunctivitis Eye swab 55 yr Out-Jaén ND ND ND
925O_04 Keratoconjunctivitis Eye swab 61 yr Out-Jaén ND ND ND
D0005_01 Diarrhea Feces <14 yr sporadic - ND +
D0007_01 Diarrhea Feces <14 yr sporadic - ND +
D0001_01 Diarrhea Feces <14 yr sporadic - ND +
D0011_01 Diarrhea Feces <14 yr sporadic - ND +
D0002_01 Diarrhea Feces <14 yr sporadic - ND +
D0004_01 Diarrhea Feces <14 yr sporadic - ND +
D0015_01 Diarrhea Feces <14 yr sporadic - ND +
D0016_01 Diarrhea Feces <14 yr sporadic - ND +
D0017_01 Diarrhea Feces <14 yr sporadic - ND +
R1650_04 BMTx, Diarrhea Feces <5yr sporadic Hep-2 + ND
R1641_04 BMTx, Diarrhea Feces <5yr sporadic Hep-2 + ND
C1640_03 BMTx, Diarrhea Feces 6yr sporadic HEF + ND
R1647_04 BMTx, Diarrhea Feces <5yr sporadic Hep-2 + ND
C5335_01 BMTx, pneumonia BAL+Biopsy 49yr sporadic HEF + ND
594_89 HIV+, Diarrhea Feces >40yr sporadic Hep-2 + ND
4030_96 Influenza-like Feces 3yr sporadic Hep-2 + ND
C1662_03 Bronchiolitis NPA 5mo sporadic HEF + ND
C1491_02 Bronchiolitis NPA 1mo sporadic HEF + ND
C1519_02 Bronchiolitis NPA 15mo sporadic HEF + ND
C1201_00 Bronchiolitis NPA 8mo sporadic HEF + ND
G3093_03 LRI Feces 30 yr sporadic Hep-2 + ND
C1167_00 LRI NPA 3mo sporadic HEF + ND
859_96 Keratoconjunctivitis Eye swab >40yr out-Tenerife Hep-2 + ND
860_96 Keratoconjunctivitis Eye swab >40yr out-Tenerife Hep-2 + ND
519_93 Keratoconjunctivitis Eye swab >40yr out-Toledo Hep-2 + ND
856_96 Keratoconjunctivitis Eye swab >40yr out-Tenerife Hep-2 + ND
615_96 Keratoconjunctivitis Eye swab >40yr out-Pamplona Hep-2 + ND
636_96 Keratoconjunctivitis Eye swab >40yr out-Pamplona Hep-2 + ND
647_96 Keratoconjunctivitis Eye swab >40yr out-Pamplona Hep-2 + ND
841_94 Keratoconjunctivitis Eye swab >40yr sporadic Hep-2 + ND
43024_02 Keratoconjunctivitis TS >40yr out-Madrid HEF + ND
C4292_02 Keratoconjunctivitis Eye swab >40yr out-Madrid HEF + ND
C1629_02 newborn control NPA 0d sporadic HEF + ND
G1T4_03 environmental water --- --- ---- A549 + ND
2
11
a Clinical sample ID_year and Isolate_year (boldface).1
2
bCells were collected and stained by standard methods. In respiratory samples HAdV infection was3
detected by direct IFA with monoclonal antibodies (Chemicon, Temecula, CA). The IFA was carried4
out with fluorescein isothiocyanate FITC)-conjugate goat anti-mouse IgG (Sigma). Monoclonal5
antibodies for detection of6
fusion protein (F0/F1) of all strains of parainfluenza virus type 1, and haemagglutinin of all strains of7
parainfluenza viruses types 2 and 3, for enteroviruses were also obtained from Chemicon.. All8
specimens were collected in 3 ml of virus transport medium (MEM, Gibco-BRL, Life Technologies,9
Paisley, Scotland; penicillin 200U/ml, and streptomycin 200 mg/ml, BioWhittaker, MA; mycostatin10
200U/ml, Sigma; bovine serum albumin 0.25%, Merck, Darmstadt, Germany). Stool samples were11
tested for HAdV (HAdV-40 and -41) by latex agglutination (Adenolex, Orion, Helsinki, Finland)12
13
Abbreviations: BMT, bone marrow transplant; LITx, liver and intestinal transplant; NPA,14
nasopharyngeal aspirates; TS, throat swab; BAL, bronchoalveolar lavage; NW, nasal wash; LA, latex15
agglutination; cont, contamination of cell cultures; ND, not done; Out-, outbreak; HEF: human16














G1066_01 C 79 HAdV-2 98,5 HAdV-2
SO4010_04 C 79 HAdV-2 100,0 HAdV-2
G1634_04 B 74 HAdV-3 99,0 HAdV-3
R1625_04 B 74 HAdV-3 99,0 HAdV-3
SO4425_04 B 74 HAdV-3 99,0 HAdV-3
SO4429_04 B 74 HAdV-3 99,0 HAdV-3
G1108_01 E 99 HAdV-4 93,1 HAdV-4
1292F_01 E 99 HAdV-4 95,6 HAdV-4
1803F_03 E 99 HAdV-4 93,1 HAdV-4
SO3360_01 C 99 HAdV-5 96,1 HAdV-5
SO3790_03 C 99 HAdV-5 100,0 HAdV-5
SO4366_04 C 99 HAdV-5 96,1 HAdV-5
591Fi_01 C 99 HAdV-5 99,5 HAdV-5
992Fi_01 C 99 HAdV-5 99,5 HAdV-5
130C_99 C 99 HAdV-5 99,5 HAdV-5
2549F_03 C 99 HAdV-5 99,0 HAdV-5
1804F_03 C 99 HAdV-5 98,5 HAdV-5
G1507_04 C 59 HAdV-6 99,0 HAdV-6
SO4408_04 C 59 HAdV-6 99,5 HAdV-6
SO4427_04 C 59 HAdV-6 99,5 HAdV-6
G1508_04 C 59 HAdV-6 99,0 HAdV-6
593Fi_01 C 59 HAdV-6 98,5 HAdV-6
1370I_03 C 59 HAdV-6 99,5 HAdV-6
411I_04 C 59 HAdV-6 99,5 HAdV-6
D0016_01 C 59 HAdV-6 99,5 HAdV-6
SO4363_04 C 59 HAdV-6 99,1 HAdV-6
SO4405_04 B 98 HAdV-7 genotype 2 99,5 HAdV-7 genotype 2
G1253_02 B 98 HAdV-7 genotype 2 99,5 HAdV-7 genotype 2
1184X_93 B 98 HAdV-7 genotype 2 99,5 HAdV-7 genotype 2
824O_02 B 98 HAdV-7 genotype 2 99,0 HAdV-7 genotype 2
R1629_04 B 61 HAdV-11, 34 or 35 98,2* HADV-11, 34 or 35
R1612_04 B 61 HAdV-11, 34 or 35 97,8* HADV-11, 34 or 35
1938I_89 B 61 HAdV-11, 34 or 35 99,2* HADV-11, 34 or 35
226I_03 B 71 HAdV-14 96,6 HAdV-14
D0002_01 F 99 HAdV-40 100,0 HAdV-40
D0004_01 F 99 HAdV-40 98,5 HAdV-40
D0017_01 F 99 HAdV-40 100,0 HAdV-40
D0015_01 F 99 HAdV-40 100,0 HAdV-40
D0005_01 F 99 HAdV-41 97,0 HAdV-41
D0007_01 F 99 HAdV-41 98,0 HAdV-41
D0001_01 F 99 HAdV-41 97,0 HAdV-41
D0011_01 F 99 HAdV-41 98,0 HAdV-41
928O_04 D 94 NIB; Species D (not HAdV-8) 95,5* Species D (not HAdV-8)
926O_04 D 94 NIB; Species D (not HAdV-8) 95,6* Species D (not HAdV-8)
925O_04 D 94 NIB; Species D (not HAdV-8) 95,6* Species D (not HAdV-8)
SO4390_04 D 94 NIB; Species D (not HAdV-8) 95,0* Species D (not HAdV-8)
HAdV isolates
C1519_02 C 95 HAdV-1 99,0 HAdV-1
C1662_03 C 95 HAdV-1 99,0 HAdV-1
C1491_02 C 95 HAdV-1 99,5 HAdV-1
C1629_02 B 74 HAdV-3 99,0 HAdV-3
4030_96 B 74 HAdV-3 99,0 HAdV-3
859_96 E 99 HAdV-4 92,2 HAdV-4
860_96 E 99 HAdV-4 89,4 HAdV-4
519_93 E 99 HAdV-4 90,7 HAdV-4
856_96 E 99 HAdV-4 92,7 HAdV-4
C1201_00 C 59 HAdV-6 100,0 HAdV-6
G3093_03 C 59 HAdV-6 99,0 HAdV-6
615_96 D 99 HAdV-8 100,0 HAdV-8
636_96 D 99 HAdV-8 100,0 HAdV-8
647_96 D 99 HAdV-8 100,0 HAdV-8
841_94 D 99 HAdV-8 100,0 HAdV-8
43024_02 D 99 HAdV-8 98,0 HAdV-8
C4292_02 D 99 HAdV-8 98,5 HAdV-8
R1650_04 A 99 HAdV-12 97,5 HAdV-12
R1641_04 A 99 HAdV-12 97,5 HAdV-12
C5335_01 B 99 HAdV-21 96,5 HAdV-21
R1647_04 B 71 HAdV-16 99,5 HAdV-16
C1640_03 A 99 HAdV-31 98,5 HAdV-31
G1T4_03 D 94 NIB; Species D (not HAdV-8) 97,0* Species D (not HAdV-8)
594_89 D 94 NIB; Species D (not HAdV-8) 96,1* Species D (not HAdV-8)






a species identified by bootstrap;2
b NIB: serotype not identified by bootstrap;3
c *Average score from all members of the group. Gray shading, when the NW score for the second4
highest serotype was higher than 93 %. Due to their close relationship, all cases of HAdV-2 and -65
present this situation. In any way, in all cases the highest score pointed to the correct serotype.6
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1-3, 7 3, 5, 6, 7, (11, 34, 35)a, 21








any age group 8, 11, 19, 37 4, 8, 7, species D
Acute hemorrhagic
cystitis























b Bone marrow transplant.
c Liver and intestinal transplant, fatal case.
